Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients

NCT ID: NCT06486012

Last Updated: 2025-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-23

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In earlier studies, a bi-directional link between diabetes and periodontitis has been established: high glucose levels increase the risk of periodontitis while glycemic control is likely to worsen with untreated periodontitis. The treatment of diabetic patients should include easy access from diabetes clinics to oral health care facilities to reduce the potential risks of periodontal disease, or deterioration of existing symptoms of periodontal disease. As part of a holistic approach to healthcare and its resources, more attention needs to be paid to the early detection, and prevention of oral diseases in diabetic patients. Novel testing and treatment methods can play a key role, and a good collaboration between diabetes and oral health care facilities is essential.

The aMMP-8 test can be used to assess the risk of periodontal disease. If the test is positive, latent MMP-8 is activated, so the inflammatory cascade is activated and provides real-time information. The test can also be used to monitor the success of the treatment outcome and can be used to determine the interval between maintenance treatments. In addition, patients' oral self-care should be improved, as most of the work in preventing oral diseases is done at home. The home use of photodynamic dual light therapy (aPDT) can provide additional benefits and also engage patients not only in self-care but also in the whole treatment process. Preliminary studies show that aPDT improves the treatment and maintenance outcomes, and potentially reduces the risk of periodontal disease in addition to self-care.

The combination of easy access to treatment could have wide benefits individually, and also at the community level, including the possibility of building a cost-effective preventive care pathway for patients with prediabetes, type 2 diabetes, and periodontitis, and identifying the risks of both diseases and treating already detected diseases early and in a timely manner.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2 Pre-diabetes Periodontal Diseases Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized clinical study on a medical device.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Data will be collected using individual study codes for participants. Study codes do not reveal which group the participant has belonged to.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Standard oral hygiene and home-use of Lumoral Treatment aPDT device.

Group Type EXPERIMENTAL

Lumoral Treatment

Intervention Type DEVICE

Photodynamic antibacterial dual-light device home-use with a marker substance

Standard oral hygiene

Intervention Type OTHER

Standard oral hygiene performed at home

Control group

Standard oral hygiene

Group Type ACTIVE_COMPARATOR

Standard oral hygiene

Intervention Type OTHER

Standard oral hygiene performed at home

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lumoral Treatment

Photodynamic antibacterial dual-light device home-use with a marker substance

Intervention Type DEVICE

Standard oral hygiene

Standard oral hygiene performed at home

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetic patient treated at community health care;
* At least 18 years old;
* Presence of ≥20 teeth;
* Agreement to participate in the study, and to sign a written consent form;
* Ability to cooperate with the treatment protocol according to coordinator investigator's assessment.

Exclusion Criteria

* Oral thrush;
* Known sensitivity to near-infrared or antibacterial blue light.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Helsinki

OTHER

Sponsor Role collaborator

Mehiläinen Health Care Services

UNKNOWN

Sponsor Role collaborator

Tampere University

OTHER

Sponsor Role collaborator

Wellbeing Services County of Pirkanmaa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna Maria Heikkinen, Professor

Role: PRINCIPAL_INVESTIGATOR

Wellbeing Services of County Pirkanmaa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wellbeing Services of County Pirkanmaa

Tampere, Pirkanmaa, Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Miia Ehrnrooth

Role: CONTACT

+358406615307

Mikko Kylmänen, Master of Health Care

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Miia Ehrnrooth

Role: primary

+358406615307

Mikko Kylmänen, Master of Health Care

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Ahmad R, Haque M. Oral Health Messiers: Diabetes Mellitus Relevance. Diabetes Metab Syndr Obes. 2021 Jul 1;14:3001-3015. doi: 10.2147/DMSO.S318972. eCollection 2021.

Reference Type BACKGROUND
PMID: 34234496 (View on PubMed)

Choi SE, Sima C, Pandya A. Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes. Diabetes Care. 2020 Mar;43(3):563-571. doi: 10.2337/dc19-1201. Epub 2019 Dec 27.

Reference Type BACKGROUND
PMID: 31882408 (View on PubMed)

Gasner NS, Schure RS. Periodontal Disease. 2025 May 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554590/

Reference Type BACKGROUND
PMID: 32119477 (View on PubMed)

Kononen E, Gursoy M, Gursoy UK. Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med. 2019 Jul 31;8(8):1135. doi: 10.3390/jcm8081135.

Reference Type BACKGROUND
PMID: 31370168 (View on PubMed)

Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):72-80.

Reference Type BACKGROUND
PMID: 28539867 (View on PubMed)

Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, Rengo G. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019 Mar 20;20(6):1414. doi: 10.3390/ijms20061414.

Reference Type BACKGROUND
PMID: 30897827 (View on PubMed)

Pakarinen S, Saarela RKT, Valimaa H, Heikkinen AM, Kankuri E, Noponen M, Alapulli H, Tervahartiala T, Raisanen IT, Sorsa T, Patila T. Home-Applied Dual-Light Photodynamic Therapy in the Treatment of Stable Chronic Periodontitis (HOPE-CP)-Three-Month Interim Results. Dent J (Basel). 2022 Nov 2;10(11):206. doi: 10.3390/dj10110206.

Reference Type BACKGROUND
PMID: 36354651 (View on PubMed)

Salminen A, Maatta AM, Mantyla P, Leskela J, Pietiainen M, Buhlin K, Suominen AL, Paju S, Sattler W, Sinisalo J, Pussinen PJ. Systemic Metabolic Signatures of Oral Diseases. J Dent Res. 2024 Jan;103(1):13-21. doi: 10.1177/00220345231203562. Epub 2023 Nov 15.

Reference Type BACKGROUND
PMID: 37968796 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://doi.org/10.1007/s00784-021-03871-2

Bashir, N.Z., Singh, HA. \& Virdee, S.S. Indocyanine green-mediated antimicrobial photodynamic therapy as an adjunct to periodontal therapy: a systematic review and meta-analysis. Clin Oral Invest 25, 5699-5710 (2021).

https://doi.org/10.1186/s12874-021-01303-z

Berger, V., Bour, L., Carter, K. et al. A roadmap to using randomization in clinical trials. BMC Med Res Methodol 21, 168 (2021).

https://doi.org/10.3389/fdmed.2021.709831

Borgnakke, W.S., Poudel, P. Front. Dent. Med, Volume 2 - 2021. Diabetes and Oral Health: Summary of Current Scientific Evidence for Why Transdisciplinary Collaboration Is Needed.

https://www.cdc.gov/oral-health/about/gum-periodontal-disease.html

Centers for Disease Control and Prevention (CDC), July 2023. Periodontal Disease.

https://doi.org/10.3389/froh.2022.897115

Sorsa, T, Nwhator, SO, Sakellari, D, Grigoriadis, A, Umeizudike, KA, Brandt, E, Keskin, M, Tervahartiala, T, Pärnänen, P, Gupta, S, Mohindra, R, Bostanci, N, Buduneli, N, Räisänen, IT. Front. Oral Health, 10 June 2022, Sec. Oral Infections and Microbes

https://www.who.int/news-room/fact-sheets/detail/diabetes

World Health Organization (WHO). Diabetes, Oct 2023. Newsroom, Fact sheets, Detail, Diabetes.

http://dx.doi.org/10.5888/pcd18.200594

Zhang Y., Leveille S.G., Shi L., Camhi S.M. Disparities in Preventive Oral Health Care and Periodontal Health Among Adults With Diabetes. Prev Chronic Dis 2021;18:200594

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R24021L

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.